February 6, 2025
Secondary CVD Medications Remain Underused Globally
A recent PURE study has found that secondary prevention medications for cardiovascular diseases (CVD), which help prevent further health complications,...
Read MorePHRI study-related publications in journals including Lancet, NEJM, JAMA and more
Read publicationsArnold L. Johnson Lectureship in Cardiology; PHRI Population Health Sciences Lectureship; and more
Learn MoreLaboratory offering genetic analysis using multi-omics, biomarker analysis, biobanking, bioinformatics services
Learn MoreWorking closely with the principal investigator(s) from initial design to completion and publication, our program directors, program managers and research coordinators support study conduct, including activity at investigative sites, sponsors internationally, and more.
Learn MorePHRI's Statistics department contributes to design, statistical analysis and data management reporting of studies. Our analysts work on large-scale multinational clinical trials, registries and epidemiological projects, ensuring a robust, reliable data platform to support sound statistical analyses and innovative methodology.
Learn MorePHRI research is powered by superlative technological solutions (development) and sophisticated, ever-evolving operations and infrastructure. The ICT team is responsible for data management systems that are at the heart of the clinical data.
Learn MoreFebruary 6, 2025
A recent PURE study has found that secondary prevention medications for cardiovascular diseases (CVD), which help prevent further health complications,...
Read MoreFebruary 3, 2025
An analysis of the ARTESiA study found that the blood thinner apixaban helps prevent stroke in people with device-detected subclinical...
Read MoreJanuary 23, 2025
PHRI Scientist Jason Roberts has been named as the inaugural Marianne Barrie/PHRI Chair in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Research,...
Read MoreBack To Top